|
|
|
Volumn 26, Issue 5 SUPPL. 15, 1999, Pages 44-51
|
|
First-line combination chemotherapy for advanced non-small cell lung cancer: The Eastern Cooperative Oncology Group and Southwest Oncology Group experience
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACIVICIN;
AMONAFIDE;
ANTHRACYCLINE ANTIBIOTIC AGENT;
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
ECHINOMYCIN;
FLUOROURACIL;
GALLIUM NITRATE;
GEMCITABINE;
IPROPLATIN;
IRINOTECAN;
MERBARONE;
METHOTREXATE;
MITOGUAZONE;
MITOMYCIN C;
NAVELBINE;
OXANTHRAZOLE;
PACLITAXEL;
PROCARBAZINE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
TAXANE DERIVATIVE;
TENIPOSIDE;
TRIMETREXATE;
UNINDEXED DRUG;
VINBLASTINE;
ADVANCED CANCER;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLOOD TOXICITY;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
META ANALYSIS;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
HUMANS;
LUNG NEOPLASMS;
PROGNOSIS;
|
|
EID: 0032703715
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (31)
|
